ARG11092
anti-SARS-CoV Spike protein antibody [1A9]
anti-SARS-CoV Spike protein antibody [1A9] for Flow cytometry,Functional study,Western blot and Virus
Overview
| Product Description | Mouse Monoclonal antibody [1A9] recognizes SARS-CoV Spike protein |
|---|---|
| Tested Reactivity | Virus |
| Tested Application | FACS, FuncSt, WB |
| Specificity | ARG11092 SARS-CoV Spike protein antibody [1A9] reacts to spike proteins from SARS-CoV, SARS-CoV-2 (2019-nCoV), Civet SARS-CoV SZ3 strain, bat SL-CoV Rp3 and Rf1 strains. |
| Host | Mouse |
| Clonality | Monoclonal |
| Clone | 1A9 |
| Isotype | IgG1 |
| Target Name | SARS-CoV Spike protein |
| Antigen Species | Virus |
| Immunogen | GST-SARS-CoV Spike protein (S delta 10 fragment, a.a. 1029-1192 ) fusion protein. |
| Epitope | Within a.a. 1111–1130 (VIGIINNTVYDPLQPELDSF) |
| Conjugation | Un-conjugated |
Application Instructions
| Application Suggestion |
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Application Note | Functional study MAb clone 1A9 is a neutralizing mAb that decreases human SARS-CoV and civet SARS-CoV infection (PMID: 25019613).
* The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
Properties
| Form | Liquid |
|---|---|
| Purification | Purification with Protein G. |
| Buffer | PBS |
| Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
| Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
| Gene Full Name | Severe acute respiratory syndrome coronavirus Spike protein |
|---|---|
| Highlight | Related products: SARS-CoV antibodies; SARS-CoV ELISA Kits; SARS-CoV recombinant proteins; Anti-Mouse IgG secondary antibodies; Related news: HMGB1, a biomarker and therapeutic target in COVID-19 ACE2, receptor of 2019-nCoV Exploring Antiviral Immune Response |
